- Time of issue:2020-06-18 00:00:00
As a clinical stage biotech company based on innovative immunology research, we root in China with the global vision to develop safe and highly efficacious novel treatments for cancer and autoimmune diseases.
Based on our proprietary antibody research and technology platforms, and guided by our core strength in IP development and innovation, we aim to lead the development of new treatments based on novel targets in mono or combination therapies.
Scan the QR code to read on your phone
Zhong Guancun Biopharmaceutical Park, NO.5 Kaituo Road,
Haidian District, Beijing City, China, 10084
A1 Northern Building, 218 Xinghu St. Suzhou Industrial Park, Jiangsu Province, China, 215123
COPYRIGHT @2020 Suzhou xinkanghe Biomedical Technology Co., Ltd 苏ICP备19068714号-1 Power by 300.cn Beijing